nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.118	0.363	CbGbCtD
Capecitabine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.118	0.363	CbGbCtD
Capecitabine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0892	0.275	CbGbCtD
Capecitabine—DPYD—bronchus—chronic obstructive pulmonary disease	0.00992	0.112	CbGeAlD
Capecitabine—TYMP—respiratory system—chronic obstructive pulmonary disease	0.00698	0.079	CbGeAlD
Capecitabine—DPYD—lung—chronic obstructive pulmonary disease	0.0064	0.0724	CbGeAlD
Capecitabine—TYMP—connective tissue—chronic obstructive pulmonary disease	0.00614	0.0695	CbGeAlD
Capecitabine—CES1—respiratory system—chronic obstructive pulmonary disease	0.00603	0.0682	CbGeAlD
Capecitabine—TYMS—respiratory system—chronic obstructive pulmonary disease	0.00599	0.0677	CbGeAlD
Capecitabine—TYMP—bronchus—chronic obstructive pulmonary disease	0.00575	0.065	CbGeAlD
Capecitabine—TYMP—smooth muscle tissue—chronic obstructive pulmonary disease	0.00562	0.0636	CbGeAlD
Capecitabine—CES1—connective tissue—chronic obstructive pulmonary disease	0.0053	0.06	CbGeAlD
Capecitabine—TYMS—connective tissue—chronic obstructive pulmonary disease	0.00527	0.0596	CbGeAlD
Capecitabine—TYMP—trachea—chronic obstructive pulmonary disease	0.00516	0.0584	CbGeAlD
Capecitabine—TYMS—bronchus—chronic obstructive pulmonary disease	0.00493	0.0558	CbGeAlD
Capecitabine—TYMS—smooth muscle tissue—chronic obstructive pulmonary disease	0.00482	0.0546	CbGeAlD
Capecitabine—TYMP—lung—chronic obstructive pulmonary disease	0.00371	0.0419	CbGeAlD
Capecitabine—CES1—lung—chronic obstructive pulmonary disease	0.0032	0.0362	CbGeAlD
Capecitabine—TYMS—lung—chronic obstructive pulmonary disease	0.00318	0.036	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—MMP1—chronic obstructive pulmonary disease	0.00169	0.0439	CbGpPWpGaD
Capecitabine—TYMS—Trans-sulfuration and one carbon metabolism—GCLC—chronic obstructive pulmonary disease	0.00153	0.0399	CbGpPWpGaD
Capecitabine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00113	0.0293	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—CXCL8—chronic obstructive pulmonary disease	0.00108	0.0282	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00105	0.0272	CbGpPWpGaD
Capecitabine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00103	0.0267	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00101	0.0262	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000888	0.0231	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—VEGFA—chronic obstructive pulmonary disease	0.000881	0.0229	CbGpPWpGaD
Capecitabine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000819	0.0213	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—EGFR—chronic obstructive pulmonary disease	0.000792	0.0206	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000792	0.0206	CbGpPWpGaD
Capecitabine—TYMS—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.000747	0.1	CbGdCrCtD
Capecitabine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000746	0.0194	CbGpPWpGaD
Capecitabine—TYMS—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.000738	0.0992	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.00073	0.0982	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00073	0.0981	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00072	0.0968	CbGdCrCtD
Capecitabine—CES1—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000718	0.0187	CbGpPWpGaD
Capecitabine—TYMS—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.000713	0.0958	CbGdCrCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.0007	0.0182	CbGpPWpGaD
Capecitabine—TYMS—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.000673	0.0905	CbGdCrCtD
Capecitabine—TYMP—Bladder Cancer—TP53—chronic obstructive pulmonary disease	0.000665	0.0173	CbGpPWpGaD
Capecitabine—TYMS—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.000657	0.0883	CbGdCrCtD
Capecitabine—CES1—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000657	0.0171	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000633	0.0165	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000623	0.0162	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000615	0.016	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000611	0.0159	CbGpPWpGaD
Capecitabine—TYMS—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.00059	0.0793	CbGdCrCtD
Capecitabine—TYMS—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.000576	0.0774	CbGdCrCtD
Capecitabine—TYMS—Danazol—Prednisone—chronic obstructive pulmonary disease	0.000565	0.076	CbGdCrCtD
Capecitabine—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000542	0.0141	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—APIP—chronic obstructive pulmonary disease	0.000539	0.014	CbGpPWpGaD
Capecitabine—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000521	0.0136	CbGpPWpGaD
Capecitabine—CDA—Metabolism—APIP—chronic obstructive pulmonary disease	0.00048	0.0125	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000476	0.0124	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000467	0.0121	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000461	0.012	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000454	0.0118	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000427	0.0111	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000423	0.011	CbGpPWpGaD
Capecitabine—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000394	0.0102	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APIP—chronic obstructive pulmonary disease	0.000384	0.00999	CbGpPWpGaD
Capecitabine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.000708	CcSEcCtD
Capecitabine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000383	0.000708	CcSEcCtD
Capecitabine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000382	0.000707	CcSEcCtD
Capecitabine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.000706	CcSEcCtD
Capecitabine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000382	0.000706	CcSEcCtD
Capecitabine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000381	0.000704	CcSEcCtD
Capecitabine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.000701	CcSEcCtD
Capecitabine—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000379	0.00985	CbGpPWpGaD
Capecitabine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000378	0.000699	CcSEcCtD
Capecitabine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000377	0.000697	CcSEcCtD
Capecitabine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000377	0.000697	CcSEcCtD
Capecitabine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000377	0.000696	CcSEcCtD
Capecitabine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000374	0.000692	CcSEcCtD
Capecitabine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.000687	CcSEcCtD
Capecitabine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.000682	CcSEcCtD
Capecitabine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.00068	CcSEcCtD
Capecitabine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000368	0.00068	CcSEcCtD
Capecitabine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000366	0.000676	CcSEcCtD
Capecitabine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.000676	CcSEcCtD
Capecitabine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.000675	CcSEcCtD
Capecitabine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.000673	CcSEcCtD
Capecitabine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000364	0.000673	CcSEcCtD
Capecitabine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00067	CcSEcCtD
Capecitabine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000362	0.000669	CcSEcCtD
Capecitabine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.000667	CcSEcCtD
Capecitabine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000359	0.000664	CcSEcCtD
Capecitabine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.000664	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000359	0.000663	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.000663	CcSEcCtD
Capecitabine—DPYD—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000357	0.00929	CbGpPWpGaD
Capecitabine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.000658	CcSEcCtD
Capecitabine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000356	0.000658	CcSEcCtD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000354	0.00922	CbGpPWpGaD
Capecitabine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.000655	CcSEcCtD
Capecitabine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000354	0.000654	CcSEcCtD
Capecitabine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000352	0.000651	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000351	0.000649	CcSEcCtD
Capecitabine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.000648	CcSEcCtD
Capecitabine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000351	0.000648	CcSEcCtD
Capecitabine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000349	0.000644	CcSEcCtD
Capecitabine—DPYD—Metabolism—GC—chronic obstructive pulmonary disease	0.000347	0.00904	CbGpPWpGaD
Capecitabine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.000642	CcSEcCtD
Capecitabine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000346	0.00064	CcSEcCtD
Capecitabine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.00064	CcSEcCtD
Capecitabine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000346	0.00064	CcSEcCtD
Capecitabine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000345	0.000638	CcSEcCtD
Capecitabine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000342	0.000632	CcSEcCtD
Capecitabine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000341	0.00063	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00034	0.000628	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.000628	CcSEcCtD
Capecitabine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000339	0.000627	CcSEcCtD
Capecitabine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.000627	CcSEcCtD
Capecitabine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000339	0.000627	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.000626	CcSEcCtD
Capecitabine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000337	0.000622	CcSEcCtD
Capecitabine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000337	0.000622	CcSEcCtD
Capecitabine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000337	0.000622	CcSEcCtD
Capecitabine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000337	0.000622	CcSEcCtD
Capecitabine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.000621	CcSEcCtD
Capecitabine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000335	0.00062	CcSEcCtD
Capecitabine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000335	0.00062	CcSEcCtD
Capecitabine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.000617	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000333	0.000615	CcSEcCtD
Capecitabine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000332	0.000614	CcSEcCtD
Capecitabine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.000612	CcSEcCtD
Capecitabine—TYMS—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.00033	0.00859	CbGpPWpGaD
Capecitabine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00033	0.000609	CcSEcCtD
Capecitabine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000329	0.000609	CcSEcCtD
Capecitabine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000329	0.000608	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000328	0.00854	CbGpPWpGaD
Capecitabine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000328	0.000605	CcSEcCtD
Capecitabine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000328	0.000605	CcSEcCtD
Capecitabine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.000604	CcSEcCtD
Capecitabine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000327	0.000604	CcSEcCtD
Capecitabine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000326	0.000602	CcSEcCtD
Capecitabine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000326	0.000602	CcSEcCtD
Capecitabine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000325	0.0006	CcSEcCtD
Capecitabine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.000599	CcSEcCtD
Capecitabine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000324	0.000599	CcSEcCtD
Capecitabine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000324	0.000599	CcSEcCtD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000324	0.00843	CbGpPWpGaD
Capecitabine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.000597	CcSEcCtD
Capecitabine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000323	0.000597	CcSEcCtD
Capecitabine—DPYD—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000323	0.0084	CbGpPWpGaD
Capecitabine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000322	0.000596	CcSEcCtD
Capecitabine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000322	0.000595	CcSEcCtD
Capecitabine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.000595	CcSEcCtD
Capecitabine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000322	0.000594	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.000593	CcSEcCtD
Capecitabine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.000592	CcSEcCtD
Capecitabine—CDA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000318	0.00828	CbGpPWpGaD
Capecitabine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.000587	CcSEcCtD
Capecitabine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.000587	CcSEcCtD
Capecitabine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000315	0.000582	CcSEcCtD
Capecitabine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000315	0.000582	CcSEcCtD
Capecitabine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000315	0.000582	CcSEcCtD
Capecitabine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.000578	CcSEcCtD
Capecitabine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000313	0.000578	CcSEcCtD
Capecitabine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.000575	CcSEcCtD
Capecitabine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000311	0.000575	CcSEcCtD
Capecitabine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.000575	CcSEcCtD
Capecitabine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000311	0.000575	CcSEcCtD
Capecitabine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00031	0.000573	CcSEcCtD
Capecitabine—CDA—Metabolism—GC—chronic obstructive pulmonary disease	0.00031	0.00805	CbGpPWpGaD
Capecitabine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000307	0.000568	CcSEcCtD
Capecitabine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000307	0.000568	CcSEcCtD
Capecitabine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000307	0.000568	CcSEcCtD
Capecitabine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000306	0.000566	CcSEcCtD
Capecitabine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.000566	CcSEcCtD
Capecitabine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000305	0.000565	CcSEcCtD
Capecitabine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000305	0.000564	CcSEcCtD
Capecitabine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000305	0.000563	CcSEcCtD
Capecitabine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000305	0.000563	CcSEcCtD
Capecitabine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000304	0.000562	CcSEcCtD
Capecitabine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.000562	CcSEcCtD
Capecitabine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000301	0.000557	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000301	0.00784	CbGpPWpGaD
Capecitabine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000301	0.000556	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.0003	0.00781	CbGpPWpGaD
Capecitabine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.0003	0.000554	CcSEcCtD
Capecitabine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.0003	0.000554	CcSEcCtD
Capecitabine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000298	0.000552	CcSEcCtD
Capecitabine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.000546	CcSEcCtD
Capecitabine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.000543	CcSEcCtD
Capecitabine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.000543	CcSEcCtD
Capecitabine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00029	0.000536	CcSEcCtD
Capecitabine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00029	0.000536	CcSEcCtD
Capecitabine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.000535	CcSEcCtD
Capecitabine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000289	0.000534	CcSEcCtD
Capecitabine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000289	0.000534	CcSEcCtD
Capecitabine—CDA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000288	0.00749	CbGpPWpGaD
Capecitabine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000287	0.00053	CcSEcCtD
Capecitabine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000284	0.000525	CcSEcCtD
Capecitabine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000282	0.000522	CcSEcCtD
Capecitabine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.000522	CcSEcCtD
Capecitabine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.000515	CcSEcCtD
Capecitabine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000278	0.000515	CcSEcCtD
Capecitabine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000278	0.000514	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000278	0.000514	CcSEcCtD
Capecitabine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000277	0.000511	CcSEcCtD
Capecitabine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000507	CcSEcCtD
Capecitabine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.000506	CcSEcCtD
Capecitabine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000273	0.000504	CcSEcCtD
Capecitabine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.000498	CcSEcCtD
Capecitabine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000269	0.000498	CcSEcCtD
Capecitabine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000268	0.000495	CcSEcCtD
Capecitabine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.000493	CcSEcCtD
Capecitabine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00049	CcSEcCtD
Capecitabine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000264	0.000487	CcSEcCtD
Capecitabine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.000486	CcSEcCtD
Capecitabine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.000483	CcSEcCtD
Capecitabine—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00026	0.00677	CbGpPWpGaD
Capecitabine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00026	0.000481	CcSEcCtD
Capecitabine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.000481	CcSEcCtD
Capecitabine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000255	0.000471	CcSEcCtD
Capecitabine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000471	CcSEcCtD
Capecitabine—TYMP—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000254	0.00662	CbGpPWpGaD
Capecitabine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00047	CcSEcCtD
Capecitabine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.000462	CcSEcCtD
Capecitabine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00025	0.000462	CcSEcCtD
Capecitabine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.000459	CcSEcCtD
Capecitabine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000248	0.000459	CcSEcCtD
Capecitabine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000248	0.000458	CcSEcCtD
Capecitabine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.000458	CcSEcCtD
Capecitabine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000458	CcSEcCtD
Capecitabine—TYMP—Metabolism—GC—chronic obstructive pulmonary disease	0.000247	0.00644	CbGpPWpGaD
Capecitabine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.000456	CcSEcCtD
Capecitabine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000247	0.000456	CcSEcCtD
Capecitabine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000455	CcSEcCtD
Capecitabine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.000455	CcSEcCtD
Capecitabine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.000454	CcSEcCtD
Capecitabine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000454	CcSEcCtD
Capecitabine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000245	0.000453	CcSEcCtD
Capecitabine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000243	0.000449	CcSEcCtD
Capecitabine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000243	0.000449	CcSEcCtD
Capecitabine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.000448	CcSEcCtD
Capecitabine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000242	0.000447	CcSEcCtD
Capecitabine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000241	0.000446	CcSEcCtD
Capecitabine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000442	CcSEcCtD
Capecitabine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00044	CcSEcCtD
Capecitabine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00044	CcSEcCtD
Capecitabine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.000437	CcSEcCtD
Capecitabine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.000435	CcSEcCtD
Capecitabine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.000434	CcSEcCtD
Capecitabine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.000433	CcSEcCtD
Capecitabine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.000433	CcSEcCtD
Capecitabine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.000433	CcSEcCtD
Capecitabine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.000432	CcSEcCtD
Capecitabine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000234	0.000432	CcSEcCtD
Capecitabine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00043	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00023	0.00599	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00023	0.00599	CbGpPWpGaD
Capecitabine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.000424	CcSEcCtD
Capecitabine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000229	0.000423	CcSEcCtD
Capecitabine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000417	CcSEcCtD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000225	0.00585	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000222	0.00578	CbGpPWpGaD
Capecitabine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000222	0.00041	CcSEcCtD
Capecitabine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.000408	CcSEcCtD
Capecitabine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.000406	CcSEcCtD
Capecitabine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000405	CcSEcCtD
Capecitabine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000403	CcSEcCtD
Capecitabine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000396	CcSEcCtD
Capecitabine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.000394	CcSEcCtD
Capecitabine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00021	0.000387	CcSEcCtD
Capecitabine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.000384	CcSEcCtD
Capecitabine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000381	CcSEcCtD
Capecitabine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000376	CcSEcCtD
Capecitabine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000374	CcSEcCtD
Capecitabine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000365	CcSEcCtD
Capecitabine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000364	CcSEcCtD
Capecitabine—TYMS—Metabolism—APIP—chronic obstructive pulmonary disease	0.000196	0.00511	CbGpPWpGaD
Capecitabine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000195	0.00036	CcSEcCtD
Capecitabine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.000356	CcSEcCtD
Capecitabine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000356	CcSEcCtD
Capecitabine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.000354	CcSEcCtD
Capecitabine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000353	CcSEcCtD
Capecitabine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000351	CcSEcCtD
Capecitabine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000351	CcSEcCtD
Capecitabine—DPYD—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00019	0.00494	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000189	0.00492	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000188	0.00488	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000187	0.00487	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000182	0.00475	CbGpPWpGaD
Capecitabine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000337	CcSEcCtD
Capecitabine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00033	CcSEcCtD
Capecitabine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000325	CcSEcCtD
Capecitabine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.000325	CcSEcCtD
Capecitabine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000324	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000174	0.00454	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000172	0.00449	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000171	0.00445	CbGpPWpGaD
Capecitabine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000316	CcSEcCtD
Capecitabine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000315	CcSEcCtD
Capecitabine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000314	CcSEcCtD
Capecitabine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.000313	CcSEcCtD
Capecitabine—CDA—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000169	0.0044	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000167	0.00435	CbGpPWpGaD
Capecitabine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000308	CcSEcCtD
Capecitabine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000303	CcSEcCtD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00425	CbGpPWpGaD
Capecitabine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000299	CcSEcCtD
Capecitabine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000299	CcSEcCtD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000161	0.0042	CbGpPWpGaD
Capecitabine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000298	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000296	CcSEcCtD
Capecitabine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000295	CcSEcCtD
Capecitabine—DPYD—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.0041	CbGpPWpGaD
Capecitabine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00029	CcSEcCtD
Capecitabine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000286	CcSEcCtD
Capecitabine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000284	CcSEcCtD
Capecitabine—CDA—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000153	0.00397	CbGpPWpGaD
Capecitabine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000282	CcSEcCtD
Capecitabine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000281	CcSEcCtD
Capecitabine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000279	CcSEcCtD
Capecitabine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000278	CcSEcCtD
Capecitabine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000277	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000149	0.00388	CbGpPWpGaD
Capecitabine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000273	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000147	0.00382	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000261	CcSEcCtD
Capecitabine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00026	CcSEcCtD
Capecitabine—CDA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000141	0.00366	CbGpPWpGaD
Capecitabine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000259	CcSEcCtD
Capecitabine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000257	CcSEcCtD
Capecitabine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000252	CcSEcCtD
Capecitabine—TYMP—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000135	0.00352	CbGpPWpGaD
Capecitabine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000249	CcSEcCtD
Capecitabine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000248	CcSEcCtD
Capecitabine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000248	CcSEcCtD
Capecitabine—TYMP—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000134	0.00348	CbGpPWpGaD
Capecitabine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000247	CcSEcCtD
Capecitabine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000247	CcSEcCtD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.00345	CbGpPWpGaD
Capecitabine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000245	CcSEcCtD
Capecitabine—DPYD—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000131	0.00342	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00013	0.00339	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00013	0.00337	CbGpPWpGaD
Capecitabine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000236	CcSEcCtD
Capecitabine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000234	CcSEcCtD
Capecitabine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000234	CcSEcCtD
Capecitabine—TYMS—Metabolism—GC—chronic obstructive pulmonary disease	0.000127	0.00329	CbGpPWpGaD
Capecitabine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000227	CcSEcCtD
Capecitabine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000226	CcSEcCtD
Capecitabine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000226	CcSEcCtD
Capecitabine—TYMP—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000122	0.00317	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000121	0.00314	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000118	0.00306	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000117	0.00305	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000117	0.00303	CbGpPWpGaD
Capecitabine—CDA—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000116	0.00301	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000115	0.003	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.00298	CbGpPWpGaD
Capecitabine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000211	CcSEcCtD
Capecitabine—TYMP—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00292	CbGpPWpGaD
Capecitabine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000205	CcSEcCtD
Capecitabine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000202	CcSEcCtD
Capecitabine—CDA—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000108	0.0028	CbGpPWpGaD
Capecitabine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000196	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000105	0.00274	CbGpPWpGaD
Capecitabine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000189	CcSEcCtD
Capecitabine—CDA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.00266	CbGpPWpGaD
Capecitabine—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.85e-05	0.000182	CcSEcCtD
Capecitabine—Rash—Prednisone—chronic obstructive pulmonary disease	9.76e-05	0.00018	CcSEcCtD
Capecitabine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.76e-05	0.00018	CcSEcCtD
Capecitabine—Headache—Prednisone—chronic obstructive pulmonary disease	9.7e-05	0.000179	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.69e-05	0.00252	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	9.65e-05	0.00251	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.55e-05	0.00249	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	9.47e-05	0.00246	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.37e-05	0.00244	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.24e-05	0.0024	CbGpPWpGaD
Capecitabine—Nausea—Prednisone—chronic obstructive pulmonary disease	9.2e-05	0.00017	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	9.01e-05	0.00235	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.61e-05	0.00224	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.19e-05	0.00213	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.16e-05	0.00212	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.08e-05	0.0021	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.97e-05	0.00207	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	7.95e-05	0.00207	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ALB—chronic obstructive pulmonary disease	7.79e-05	0.00203	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	7.63e-05	0.00199	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—NOS3—chronic obstructive pulmonary disease	7.45e-05	0.00194	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.42e-05	0.00193	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.32e-05	0.00191	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.04e-05	0.00183	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	6.98e-05	0.00182	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.94e-05	0.00181	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ALB—chronic obstructive pulmonary disease	6.94e-05	0.00181	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.92e-05	0.0018	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GCLC—chronic obstructive pulmonary disease	6.84e-05	0.00178	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NOS3—chronic obstructive pulmonary disease	6.64e-05	0.00173	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CTGF—chronic obstructive pulmonary disease	6.24e-05	0.00162	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.75e-05	0.0015	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.66e-05	0.00147	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALB—chronic obstructive pulmonary disease	5.55e-05	0.00144	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NOS3—chronic obstructive pulmonary disease	5.31e-05	0.00138	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.79e-05	0.00125	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.73e-05	0.00123	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.4e-05	0.00115	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.18e-05	0.00109	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.04e-05	0.00105	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.75e-05	0.000976	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.72e-05	0.000968	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.65e-05	0.000949	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TP53—chronic obstructive pulmonary disease	3.44e-05	0.000895	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.39e-05	0.000883	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALB—chronic obstructive pulmonary disease	2.84e-05	0.000739	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NOS3—chronic obstructive pulmonary disease	2.72e-05	0.000707	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.7e-05	0.000703	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.99e-05	0.000519	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.97e-05	0.000513	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.84e-05	0.000478	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.8e-05	0.000468	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.000431	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.38e-05	0.00036	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.36e-05	0.000355	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.27e-05	0.00033	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000313	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	8.18e-06	0.000213	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.83e-06	0.000204	CbGpPWpGaD
